MYMD Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2022 | Paul Rivard, Esq. Chief Legal Officer | 161,827 | 20,000 | 0 | 0 | 6,412 | 188,239 |
| 2023-06-30 | 2021 | Adam Kaplin, M.D., PhD Chief Scientific Officer | 250,000 | 126,724 | 4,854,000 | 0 | 0 | 5,230,724 |
| 2023-06-30 | 2022 | Adam Kaplin, M.D., PhD Chief Scientific Officer | 245,153 | 100,000 | 0 | 0 | 8,580 | 353,733 |
| 2023-06-30 | 2021 | Christopher Chapman, M.D. President, Chief Medical Officer | 165,000 | 121,540 | 4,854,000 | 0 | 0 | 5,140,540 |
| 2023-06-30 | 2022 | Christopher Chapman, M.D. President, Chief Medical Officer | 161,827 | 100,000 | 0 | 0 | 0 | 261,827 |
| 2023-06-30 | 2021 | Paul Rivard, Esq. Chief Legal Officer | 165,000 | 60,000 | 1,618,000 | 0 | 0 | 1,843,000 |
| 2022-10-26 | 2020 | Adam Kaplin, M.D., PhD Chief Scientific Officer | 20,833 | 100,000 | 0 | 0 | 0 | 360,833 |
| 2022-10-26 | 2020 | Christopher Schreiber Former President and Chief Executive Officer | 300,000 | 150,000 | 590,240 | 0 | 57,618 | 1,097,858 |
| 2022-10-26 | 2021 | Christopher Schreiber Former President and Chief Executive Officer | 300,000 | 0 | 1,213,500 | 0 | 0 | 1,513,500 |
| 2022-10-26 | 2021 | Paul Rivard, Esq., Executive Vice President of Operations and General Counsel | 165,000 | 60,000 | 1,618,000 | 0 | 0 | 1,843,000 |
| 2022-10-26 | 2020 | Paul Rivard, Esq., Executive Vice President of Operations and General Counsel | 55,000 | 0 | 0 | 0 | 0 | 175,000 |
| 2022-10-26 | 2021 | Christopher Chapman, M.D. President, Chief Medical Officer | 165,000 | 121,540 | 4,854,000 | 0 | 0 | 5,140,540 |
| 2022-10-26 | 2020 | Christopher Chapman, M.D. President, Chief Medical Officer | 27,500 | 0 | 0 | 0 | 0 | 297,500 |
| 2022-10-26 | 2021 | Adam Kaplin, M.D., PhD Chief Scientific Officer | 250,000 | 126,724 | 4,854,000 | 0 | 0 | 5,230,724 |
| 2021-11-22 | 2019 | Chris Chapman, M.D. President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-11-22 | 2019 | Adam Kaplin, M.D., Ph.D. Chief Scientific Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-11-22 | 2020 | Adam Kaplin, M.D., Ph.D. Chief Scientific Officer | 27,500 | 0 | 0 | 0 | 0 | 297,500 |
| 2021-11-22 | 2020 | Chris Chapman, M.D. President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-11-22 | 2019 | James A. McNulty, CPA Former Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary | 0 | 0 | 0 | 0 | 0 | 293,500 |
| 2020-07-29 | 2019 | Christopher C. Schreiber | 50,000 | 0 | 0 | 0 | 0 | 50,000 |
| 2020-07-29 | 2019 | Howard R. Yeaton | 300,000 | 0 | 26,302 | 0 | 0 | 326,302 |
| 2019-11-12 | 2017 | Raymond F. Akers, Jr PhD Secretary and Chief Scientific Director | 288,462 | 0 | 0 | 0 | 0 | 296,262 |
| 2019-11-12 | 2018 | Chief Executive Officer and Interim Chief Financial Officer | 71,774 | 0 | 0 | 0 | 0 | 92,715 |
| 2019-11-12 | 2017 | Chief Executive Officer and Interim Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2019-11-12 | 2018 | John J. Gormally Former Chief Executive Officer | 260,360 | 100,000 | 0 | 0 | 0 | 366,860 |
| 2019-11-12 | 2017 | John J. Gormally Former Chief Executive Officer | 322,115 | 50,000 | 0 | 0 | 0 | 511,915 |
| 2019-11-12 | 2018 | Raymond F. Akers, Jr PhD Secretary and Chief Scientific Director | 115,231 | 0 | 0 | 0 | 0 | 118,481 |
| 2018-11-14 | 2016 | Raymond F. Akers, Jr PhD Former Secretary and Chief Scientific Director | 269,231 | 0 | 0 | 0 | 0 | 277,031 |
| 2018-11-14 | 2017 | John J. Gormally Former Chief Executive Officer | 322,115 | 50,000 | 0 | 0 | 0 | 511,915 |
| 2018-11-14 | 2016 | John J. Gormally Former Chief Executive Officer | 248,500 | 0 | 0 | 0 | 0 | 311,025 |
| 2018-11-14 | 2017 | Gary M. Rauch Vice President of Finance and Treasurer | 111,031 | 18,900 | 0 | 0 | 0 | 161,855 |
| 2018-11-14 | 2016 | Gary M. Rauch Vice President of Finance and Treasurer | 95,000 | 0 | 0 | 0 | 0 | 95,000 |
| 2018-11-14 | 2017 | Raymond F. Akers, Jr PhD Former Secretary and Chief Scientific Director | 288,462 | 0 | 0 | 0 | 0 | 296,262 |
| 2017-07-24 | 2016 | Former Executive Chairman Secretary, Chief Scientific Director | 269,231 | 0 | 0 | 0 | 0 | 277,031 |
| 2017-07-24 | 2015 | Former Executive Chairman Secretary, Chief Scientific Director | 397,450 | 0 | 0 | 0 | 0 | 662,150 |
| 2017-07-24 | 2016 | Chief Executive Officer | 248,500 | 0 | 0 | 0 | 0 | 311,025 |
| 2017-07-24 | 2016 | Vice President, Finance and Treasurer | 95,000 | 0 | 0 | 0 | 0 | 95,000 |
| 2017-07-24 | 2015 | Vice President, Finance and Treasurer | 95,000 | 0 | 0 | 0 | 0 | 122,675 |
| 2016-11-14 | 2015 | Vice President, Finance Treasurer | 95,000 | 0 | 0 | 0 | 0 | 122,675 |
| 2016-11-14 | 2015 | Chief Executive Officer | 24,038 | 0 | 0 | 0 | 0 | 24,688 |
| 2016-11-14 | 2014 | Former Executive Chairman Secretary, Chief Scientific Director | 394,231 | 0 | 0 | 0 | 0 | 526,301 |
| 2016-11-14 | 2015 | Former Executive Chairman Secretary, Chief Scientific Director | 397,450 | 0 | 0 | 0 | 0 | 662,150 |
| 2016-11-14 | 2014 | Vice President, Finance Treasurer | 78,414 | 2,500 | 0 | 0 | 0 | 138,765 |
| 2015-06-05 | 2012 | Raymond F Akers Jr PhD Executive Chairman, Secretary | 350,000 | 0 | 0 | 0 | 7,800 | 357,800 |
| 2015-06-05 | 2013 | Thomas A Nicolette Former Chief Executive Officer, President | 0 | 26,173 | 0 | 0 | 335,004 | 361,176 |
| 2015-06-05 | 2012 | Thomas A Nicolette Former Chief Executive Officer, President | 0 | 0 | 0 | 0 | 335,004 | 335,004 |
| 2015-06-05 | 2014 | Gary M Rauch Vice President of Finance, Treasurer | 78,414 | 2,500 | 0 | 0 | 11,250 | 138,765 |
| 2015-06-05 | 2013 | Gary M Rauch Vice President of Finance, Treasurer | 0 | 0 | 0 | 0 | 67,500 | 67,500 |
| 2015-06-05 | 2012 | Gary M Rauch Vice President of Finance, Treasurer | 0 | 0 | 0 | 0 | 67,500 | 67,500 |
| 2015-06-05 | 2014 | Raymond F Akers Jr PhD Executive Chairman, Secretary | 394,231 | 0 | 0 | 0 | 7,800 | 526,301 |
| 2015-06-05 | 2013 | Raymond F Akers Jr PhD Executive Chairman, Secretary | 347,500 | 26,173 | 0 | 0 | 7,800 | 381,473 |
| 2015-06-05 | 2014 | Thomas A Nicolette Former Chief Executive Officer, President | 0 | 100,000 | 0 | 0 | 83,751 | 183,751 |
| 2014-10-17 | 2011 | Raymond F. Akers, Jr. PhD Executive Chairman, Secretary | 345,285 | 0 | 0 | 0 | 7,800 | 353,085 |
| 2014-10-17 | 2011 | Gary Rauch, Controller, Treasurer | 0 | 0 | 0 | 0 | 41,700 | 41,700 |
| 2014-10-17 | 2012 | Gary Rauch, Controller, Treasurer | 0 | 0 | 0 | 0 | 67,500 | 67,500 |
| 2014-10-17 | 2013 | Raymond F. Akers, Jr. PhD Executive Chairman, Secretary | 347,500 | 26,173 | 0 | 0 | 7,800 | 381,473 |
| 2014-10-17 | 2012 | Raymond F. Akers, Jr. PhD Executive Chairman, Secretary | 350,000 | 0 | 0 | 0 | 7,800 | 357,800 |
| 2014-10-17 | 2013 | Gary Rauch, Controller, Treasurer | 0 | 0 | 0 | 0 | 67,500 | 67,500 |
| 2014-10-17 | 2011 | Thomas Nicolette* Chief Executive Officer, President | 0 | 0 | 0 | 0 | 333,506 | 333,506 |
| 2014-10-17 | 2012 | Thomas Nicolette* Chief Executive Officer, President | 0 | 0 | 0 | 0 | 335,004 | 335,004 |
| 2014-10-17 | 2013 | Thomas Nicolette* Chief Executive Officer, President | 0 | 26,173 | 0 | 0 | 335,004 | 361,176 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
